{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:43:39Z","timestamp":1787503419434,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.sapharm.2024.05.003","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T11:47:26Z","timestamp":1715428046000},"page":"796-803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The adverse inpatient medication event and frailty (AIME-frail) risk prediction model"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4682-7890","authenticated-orcid":false,"given":"Nazanin","family":"Falconer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Abdel-Hafez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Cottrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Centaine","family":"Snoswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebtyhal","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan Yong","family":"Jie Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Barras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.sapharm.2024.05.003_bib1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s41999-021-00481-9","article-title":"Adverse drug reactions in older adults: a narrative review of the literature","volume":"12","author":"Zazzara","year":"2021","journal-title":"European Geriatric Medicine"},{"issue":"5","key":"10.1016\/j.sapharm.2024.05.003_bib2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s40266-022-00940-3","article-title":"Scoping review of studies evaluating frailty and its association with medication harm","volume":"39","author":"Lam","year":"2022","journal-title":"Drugs Aging"},{"issue":"3","key":"10.1016\/j.sapharm.2024.05.003_bib3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00228-012-1387-2","article-title":"Medication prescribing in frail older people","volume":"69","author":"Hubbard","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.sapharm.2024.05.003_bib4","series-title":"Hospital-Acquired Complications Fact Sheets Supporting Safety and Quality in Australian Health Services","year":"2018"},{"issue":"5","key":"10.1016\/j.sapharm.2024.05.003_bib5","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/bcp.13514","article-title":"Systematic review of predictive risk models for adverse drug events in hospitalized patients","volume":"84","author":"Falconer","year":"2018","journal-title":"Br J Clin Pharmacol"},{"issue":"9868","key":"10.1016\/j.sapharm.2024.05.003_bib6","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","article-title":"Frailty in elderly people","volume":"381","author":"Clegg","year":"2013","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.sapharm.2024.05.003_bib7","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/s41598-018-38072-7","article-title":"The role of frailty in predicting mortality and readmission in older adults in acute care wards: a prospective study","volume":"9","author":"Hao","year":"2019","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.sapharm.2024.05.003_bib8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/wvn.12508","article-title":"Adverse health effects of frailty: systematic review and Meta-analysis of Middle-aged and older adults with Implications for evidence-based practice","volume":"18","author":"Chu","year":"2021","journal-title":"Worldviews Evidence-Based Nurs\/Sigma Theta Tau International, Honor Society of Nursing"},{"key":"10.1016\/j.sapharm.2024.05.003_bib9","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2147\/CIA.S216705","article-title":"Medication regimen Complexity in 8 Australian residential aged care facilities: impact of age, length of stay, comorbidity, frailty, and dependence in Activities of Daily living","volume":"14","author":"Chen","year":"2019","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.sapharm.2024.05.003_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2016.03.007","article-title":"Frailty measurement in research and clinical practice: a review","volume":"31","author":"Dent","year":"2016","journal-title":"Eur J Intern Med"},{"issue":"3","key":"10.1016\/j.sapharm.2024.05.003_bib11","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a Phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol: Series A"},{"issue":"2","key":"10.1016\/j.sapharm.2024.05.003_bib12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4235\/agmr.20.0002","article-title":"Measuring frailty in health care Databases for clinical care and research","volume":"24","author":"Kim","year":"2020","journal-title":"Ann Geriatr Med Res"},{"issue":"10132","key":"10.1016\/j.sapharm.2024.05.003_bib13","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0140-6736(18)30668-8","article-title":"Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study","volume":"391","author":"Gilbert","year":"2018","journal-title":"Lancet (London, England)"},{"issue":"4","key":"10.1016\/j.sapharm.2024.05.003_bib14","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.sapharm.2020.08.002","article-title":"Prognostic prediction models and clinical tools based on consensus to support patient prioritization for clinical pharmacy services in hospitals: a scoping review","volume":"17","author":"Botelho","year":"2021","journal-title":"Res Soc Adm Pharm"},{"issue":"3","key":"10.1016\/j.sapharm.2024.05.003_bib15","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1111\/bcp.14560","article-title":"Development and validation of the adverse inpatient medication event model (AIME)","volume":"87","author":"Falconer","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.sapharm.2024.05.003_bib16","series-title":"Australian Medicines Handbook Pty Ltd;. Adelaide","year":"2017"},{"issue":"9237","key":"10.1016\/j.sapharm.2024.05.003_bib17","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","article-title":"Adverse drug reactions: definitions, diagnosis and management","volume":"356","author":"Edwards","year":"2000","journal-title":"lancet"},{"key":"10.1016\/j.sapharm.2024.05.003_bib18","series-title":"The Use of the WHO-UMC System for Standardised Case Causality Assessment. Uppsala Monitoring Centre","year":"2013"},{"issue":"4","key":"10.1016\/j.sapharm.2024.05.003_bib19","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/qshc.2004.010611","article-title":"Adverse drug events and medication errors: detection and classification methods","volume":"13","author":"Morimoto","year":"2004","journal-title":"Quality & safety in health care"},{"issue":"6","key":"10.1016\/j.sapharm.2024.05.003_bib20","first-page":"538","article-title":"Focusing on the preventability of adverse drug reactions","volume":"27","author":"Schumock","year":"1992","journal-title":"Hosp Pharm"},{"issue":"9","key":"10.1016\/j.sapharm.2024.05.003_bib21","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.sapharm.2024.05.003_bib22","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.sapharm.2018.11.003","article-title":"How hospital pharmacists prioritise patients at high-risk for medication harm","volume":"15","author":"Falconer","year":"2019","journal-title":"Res Soc Adm Pharm"},{"issue":"3","key":"10.1016\/j.sapharm.2024.05.003_bib23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/picr.PICR_87_17","article-title":"Common pitfalls in statistical analysis: logistic regression","volume":"8","author":"Ranganathan","year":"2017","journal-title":"Perspect Clin Res"},{"key":"10.1016\/j.sapharm.2024.05.003_bib24","series-title":"R: A Language and Environment for Statistical Computing","year":"2021"},{"key":"10.1016\/j.sapharm.2024.05.003_bib25","article-title":"Clinical prediction models: a practical approach to development, validation, and updating","volume":"S","author":"Steyerberg","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.sapharm.2024.05.003_bib26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/eci.12376","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement","volume":"45","author":"Collins","year":"2015","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"10.1016\/j.sapharm.2024.05.003_bib27","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","article-title":"Assessing the performance of prediction models: a framework for traditional and novel measures","volume":"21","author":"Steyerberg","year":"2010","journal-title":"Epidemiology"},{"issue":"10","key":"10.1016\/j.sapharm.2024.05.003_bib28","article-title":"Critical Appraisal and data extraction for systematic reviews of prediction Modelling studies: the CHARMS Checklist","volume":"11","author":"Moon","year":"2014","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.sapharm.2024.05.003_bib29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/sim.2993","article-title":"Youden Index and the optimal threshold for markers with mass at zero","volume":"27","author":"Schisterman","year":"2008","journal-title":"Stat Med"},{"issue":"6","key":"10.1016\/j.sapharm.2024.05.003_bib30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"issue":"5","key":"10.1016\/j.sapharm.2024.05.003_bib31","doi-asserted-by":"crossref","first-page":"afab282","DOI":"10.1093\/ageing\/afab282","article-title":"Clinical trials in older people","volume":"51","author":"Pitkala","year":"2022","journal-title":"Age Ageing"},{"issue":"2","key":"10.1016\/j.sapharm.2024.05.003_bib32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/bcpt.13536","article-title":"Are older adults insufficiently included in clinical trials?\u2014an umbrella review","volume":"128","author":"Florisson","year":"2021","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"5","key":"10.1016\/j.sapharm.2024.05.003_bib33","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/ageing\/afx081","article-title":"Frailty status at admission to hospital predicts multiple adverse outcomes","volume":"46","author":"Hubbard","year":"2017","journal-title":"Age Ageing"},{"issue":"1","key":"10.1016\/j.sapharm.2024.05.003_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049216","article-title":"Rockwood Clinical Frailty Scale as a predictor of adverse outcomes among older adults undergoing aortic valve replacement: a protocol for a systematic review","volume":"12","author":"Prendiville","year":"2022","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.sapharm.2024.05.003_bib35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s40266-022-00940-3","article-title":"Scoping review of studies evaluating frailty and its association with medication harm","volume":"39","author":"Lam","year":"2022","journal-title":"Drugs Aging"},{"issue":"5","key":"10.1016\/j.sapharm.2024.05.003_bib36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.18773\/austprescr.2017.055","article-title":"Prescribing for frail older people","volume":"40","author":"Hilmer","year":"2017","journal-title":"Aust Prescr"},{"issue":"2","key":"10.1016\/j.sapharm.2024.05.003_bib37","first-page":"91","article-title":"Frailty assessment scales for the elderly and their application in primary care: a systematic literature review","volume":"58","author":"Dolenc","year":"2019","journal-title":"Zdr Varst"},{"issue":"5","key":"10.1016\/j.sapharm.2024.05.003_bib38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","year":"2005","journal-title":"CMAJ (Can Med Assoc J) : Canadian Medical Association journal = journal de l'Association medicale canadienne"},{"issue":"1","key":"10.1016\/j.sapharm.2024.05.003_bib39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12873-022-00730-5","article-title":"A comparison between the clinical frailty scale and the hospital frailty risk score to risk stratify older people with emergency care needs","volume":"22","author":"Alshibani","year":"2022","journal-title":"BMC Emerg Med"},{"key":"10.1016\/j.sapharm.2024.05.003_bib40","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3390\/jcm11082193","article-title":"External validation of the hospital frailty-risk score in predicting clinical outcomes in older heart-failure patients in Australia","volume":"11","author":"Sharma","year":"2022","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.sapharm.2024.05.003_bib41","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/bmjqs-2019-009587","article-title":"Medication-related harm in older adults following hospital discharge: development and validation of a prediction tool","volume":"29","author":"Parekh","year":"2020","journal-title":"BMJ Qual Saf"},{"issue":"8","key":"10.1016\/j.sapharm.2024.05.003_bib42","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/bmjqs-2018-008335","article-title":"Development and performance evaluation of the Medicines Optimisation Assessment Tool (MOAT): a prognostic model to target hospital pharmacists' input to prevent medication-related problems","volume":"28","author":"Cathy","year":"2019","journal-title":"BMJ Quality & Safety"},{"issue":"7","key":"10.1016\/j.sapharm.2024.05.003_bib43","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1016\/j.sapharm.2021.08.014","article-title":"Developing PHarmacie-R: a bedside risk prediction tool with a medicines management focus to identify risk of hospital readmission","volume":"18","author":"Criddle","year":"2022","journal-title":"Res Soc Adm Pharm"},{"issue":"2","key":"10.1016\/j.sapharm.2024.05.003_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001381","article-title":"Prognosis research strategy (PROGRESS) 3: prognostic model research","volume":"10","author":"Steyerberg","year":"2013","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.sapharm.2024.05.003_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/bmjhci-2020-100253","article-title":"Adoption of clinical risk prediction tools is limited by a lack of integration with electronic health records","volume":"28","author":"Sharma","year":"2021","journal-title":"BMJ Health Care Inform"},{"issue":"1","key":"10.1016\/j.sapharm.2024.05.003_bib46","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/ehf2.13073","article-title":"Machine learning vs. conventional statistical models for predicting heart failure readmission and mortality","volume":"8","author":"Shin","year":"2021","journal-title":"ESC Heart Fail"},{"issue":"5","key":"10.1016\/j.sapharm.2024.05.003_bib47","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.10738","article-title":"Machine learning for predicting Rare clinical outcomes\u2014finding Needles in a Haystack","volume":"4","author":"Wang","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.sapharm.2024.05.003_bib48","doi-asserted-by":"crossref","DOI":"10.1177\/2042098620975516","article-title":"Identifying medication harm in hospitalised patients: a bimodal, targeted approach","volume":"11","author":"Falconer","year":"2020","journal-title":"Ther Adv Drug Saf."},{"key":"10.1016\/j.sapharm.2024.05.003_bib49","article-title":"The clinical frailty scale \u2013 does it predict outcome of the very-old in UK ICUs?","author":"Lonsdale","year":"2022","journal-title":"J Intensive Care Soc"},{"key":"10.1016\/j.sapharm.2024.05.003_bib50","doi-asserted-by":"crossref","first-page":"e670","DOI":"10.7717\/peerj-cs.670","article-title":"Comparison of machine learning techniques to handle imbalanced COVID-19 CBC datasets","volume":"7","author":"Dorn","year":"2021","journal-title":"PeerJ Comput Sci."}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741124001724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741124001724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T15:47:06Z","timestamp":1718466426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741124001724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1551741124001724"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2024.05.003","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The adverse inpatient medication event and frailty (AIME-frail) risk prediction model","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2024.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}